T1	Participants 66 87	patients with cancer.
T2	Participants 1155 1222	342 participants from the ongoing ESRA-C randomized clinical trial.
T3	Participants 1223 1491	Research participants for the ESRA-C study were recruited from the Seattle Cancer Care Alliance, a consortium among the University of Washington Medical Center, Fred Hutchinson Cancer Research Center, and Children's Hospital and Regional Medical Center in Seattle, WA.
T4	Participants 1516 1597	342 adult participants who completed both baseline and follow-up survey sessions.
T5	Participants 1639 1656	recruitment group
